Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia
Status:
Recruiting
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to compare the uterus tissue of women who receive an
intrauterine system to treat their endometrial hyperplasia with the uterine tissue of women
who receive megestrol acetate to treat their hyperplasia. While both methods are commonly
used in practice, investigators would like to see what effects each treatment has on uterine
tissue.